Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001621 · ClinicalTrials.gov registry record
Evaluation and Treatment of Patients With Lung Disease Not Participating in Research
A clinical trial of Pulmonary Disease, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 280
- Enrollment target
- 1
- Study location
NCT00001621 is a study of Pulmonary Disease that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 280 participants, below the 610-participant average among 19 other Pulmonary Disease trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00001621, a study of Pulmonary Disease, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 280 participants
- Enrollment target
- 1
- Study location
Study Summary
This study was developed in order for the professional-staff at the Pulmonary-Critical Care Medical Branch (PCCMB) of the National Heart, Lung, and Blood Institute to maintain their skills and increase their understanding of lung diseases. The study will permit PCCMB staff members to evaluate and treat patients with lung disease who do not meet the criteria for other research studies.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 1997-02-12 |
| Est. Completion | 2020-09-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001621
The ClinicalTrials.gov registry entry for NCT00001621 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 610-participant average among 19 other Pulmonary Disease trials with a reported enrollment target (54% lower). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00001621 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001621 about?
NCT00001621 is a clinical study titled "Evaluation and Treatment of Patients With Lung Disease Not Participating in Research". This study was developed in order for the professional-staff at the Pulmonary-Critical Care Medical Branch (PCCMB) of the National Heart, Lung, and Blood Institute to maintain their skills and increase their understanding of lung diseases. The study will permit PCCMB staff members to evaluate and t...
What is the current status of trial NCT00001621?
This trial is currently completed. The enrollment target is 280 participants. The study started on 1997-02-12. Estimated completion is 2020-09-25.
What conditions does trial NCT00001621 study?
This clinical trial studies the following conditions: Pulmonary Disease.
Who is sponsoring clinical trial NCT00001621?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001621 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
RECRUITING
-
Quantitative Pulmonary Imaging Registry & Biorepository
RECRUITING
-
Merck IIT: RRP Pembro and Lenvatinib
RECRUITING · Early Phase 1
-
Study of Lung Proteins in Patients With Pneumonia
RECRUITING
-
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
RECRUITING
-
Risk Underlying Rural Areas Longitudinal Cohort Study (RURAL) Heart and Lung Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.